<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="137938">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02003781</url>
  </required_header>
  <id_info>
    <org_study_id>4-2013-0581</org_study_id>
    <nct_id>NCT02003781</nct_id>
  </id_info>
  <brief_title>Individualized Prevention Strategy for High Risk Patients in Cardiovascular Disease: Prospective Cohort Study (Cardiovascular and Metabolic Disease Etiology Research Center - HIgh Risk Cohort) CMERC-HI</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yonsei University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Yonsei University</source>
  <oversight_info>
    <authority>Korea: Ministry for Health, Welfare and Family Affairs</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Set the prospective cohort (CMERC-HI) to study the known and novel etiologies and related
      factors for predicting clinical outcomes in Korean patients with high risk cardiovascular
      disease.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2013</start_date>
  <completion_date type="Anticipated">December 2023</completion_date>
  <primary_completion_date type="Anticipated">December 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Prognosis of high risk cardiovascular disease</measure>
    <time_frame>10 year after recruting</time_frame>
    <safety_issue>No</safety_issue>
    <description>all-cause mortality, cardiovascular mortality, non-cardiovascular mortality
new onset of acute myocardial infarction, acute coronary syndrome, heart failure, stroke, peripheral artery disease, hospitalization for revascularization and these disease</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">4000</enrollment>
  <condition>High Risk Cardiovascular Disease Patients</condition>
  <arm_group>
    <arm_group_label>cardiovascular disease</arm_group_label>
    <description>high risk cardiovascular disease patients and their relatives</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      serum, whole blood, urine, DNA
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        high risk cardiovascular disease patients and their relatives
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  high risk hypertension patients a. eGFR &gt; 60 with one of target organ damages b. eGFR
             &lt;= 60

          -  diabetes mellitus with microalbumin ration (AC ratio &gt;= 30mg/g)

          -  anuric ESRD patients on dialysis

          -  the relatives of acute myocardial infarction patients under 55 years old (men)/ 65
             years old (women)

        Exclusion Criteria:

          -  acute myocardial infarction, acute coronary syndrome patients, symptomatic coronary
             artery disease or history of these diseases

          -  symptomatic peripheral artery disease, heart failure and history of these diseases

          -  desired life time under 6 months due to non-cardiovascular disease (e.g. cancer,
             sepsis)

          -  women with pregnancy or on nursing

          -  history of contrast allergy and related side effects
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Sungha Park, MD</last_name>
    <phone>82-2-2228-8455</phone>
    <email>shpark0530@yuhs.ac</email>
  </overall_contact>
  <location>
    <facility>
      <name>Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine</name>
      <address>
        <city>Seoul</city>
        <zip>120-752</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sungha Park, MD</last_name>
      <phone>82-2-2228-8455</phone>
      <email>shpark0530@yuhs.ac</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>December 2013</verification_date>
  <lastchanged_date>December 2, 2013</lastchanged_date>
  <firstreceived_date>December 2, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>cardiovascular disease</keyword>
  <keyword>metabolic disease</keyword>
  <keyword>high risk</keyword>
  <keyword>prospective cohort</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Cardiovascular Diseases</mesh_term>
    <mesh_term>Metabolic Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
